Clinical Trial Update: Iatrogenic Atrial Septal Defect Study (iASD) [Phase 3]

View source ↗

Summary

Phase 3 trial of iatrogenic atrial septal defect study was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect
• Septal Defect Atrial

Snippet

Sponsor: Henry Ford Health System | Conditions: Septal Defect, Atrial | Phase 3 | Status: WITHDRAWN